Clinical trial
Impact of HIV and Its Treatment on Reverse Cholesterol Transport
NCT00168233 · The Alfred, Other · Completed
Key facts
| NCT number | NCT00168233 |
|---|---|
| Title | Impact of HIV and Its Treatment on Reverse Cholesterol Transport |
| Official title | Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport |
| Lead sponsor | The Alfred, Other |
| Collaborators | National Health and Medical Research Council, Australia |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 44 |
| Start date | Jun 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 20, 2012 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: